Dear Contractor
The following communication was issued 16th February 2024 by SPPG to those pharmacies involved in the Community Pharmacy Care Home Support Service (CPCHSS).  

SUMMARY

  • A requirement for the Community Care Home Support Service is to complete two care home visits each financial year.
  • The second care home visit is due to be completed by the end of March 2024.
  • SPPG have recently introduced a process for partial recuperation of payments made to community pharmacists who are contracted to provide the service but have not completed the required visits in line with service specification.
  • SPPG will be in contact in early April to seek confirmation and dates of the visits completed for 23/24.

ACTION

  • Contractors should read the correspondence issued by SPPG 16th February 2024.
  • Any pharmacy yet to complete the second required care home visit should organise a date before the end of March 2024.
  • Please share this information with all relevant members of the team.

If you have any queries in relation to this service please contact Breege Brogan Breege.Brogan@hscni.net or Gillian Plant Gillian.Plant@hscni.net.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.
Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Shortage Reporter and Situation Reporter.
Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Colleague
The second update of concessionary prices were granted today for February 2024:
DrugPack SizeConcessionary Price
Amiloride 5mg tablets28£15.59
Amoxicillin 250mg/5ml oral suspension100£2.49
Betahistine 16mg tablets84£8.50
Betahistine 8mg tablets84£4.30
Betamethasone valerate 0.1% cream100£5.39
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment30£12.12
Clotrimazole 500mg pessaries1£9.56
Co-codamol 15mg/500mg tablets100£3.28
Dexamfetamine 5mg tablets28£22.75
Digoxin 62.5microgram tablets28£2.78
Docusate 50mg/5ml oral solution sugar free300£17.08
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops 0.2ml unit dose preservative free60£25.03
Duloxetine 30mg gastro-resistant capsules28£2.90
Duloxetine 40mg gastro-resistant capsules56£11.25
Escitalopram 10mg tablets28£1.27
Estradiol 10microgram pessaries24£10.75
Ezetimibe 10mg tablets28£14.65
Haloperidol 5mg tablets28£3.95
Lamotrigine 50mg tablets56£2.79
Morphine sulfate 10mg/5ml oral solution300£5.45
Orlistat 120mg capsules84£23.45
Oxycodone 5mg/5ml oral solution sugar free250£9.71
Pregabalin 150mg capsules56£2.12
Pregabalin 225mg capsules56£2.35
Rasagiline 1mg tablets28£47.98
Risperidone 2mg tablets60£1.99
Ropinirole 500microgram tablets28£15.75
Simvastatin 20mg tablets28£1.10
Sulpiride 200mg tablets30£3.20
Terbinafine 1% cream15£3.54
Terbinafine 1% cream30£6.55
Trazodone 150mg tablets28£2.18
Zolmitriptan 2.5mg tablets6£16.45
Zolmitriptan 2.5mg tablets12£32.90
Zopiclone 3.75mg tablets28£1.55
Zopiclone 7.5mg tablets28£1.56

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive

Dear Contractor

We wrote to you on 11 December 2023 highlighting the UK-wide public consultation on Pharmacy Supervision which has been launched.  The consultation will end on 29 February 2024 and can be accessed using the following link.

The consultation sets out proposals to amend the Medicines Act 1968 and The Human Medicines Regulations 2012.  The proposals are to:

  • enable pharmacists to authorise pharmacy technicians to carry out, or supervise others carrying out, the preparation, assembly, dispensing, sale and supply of medicines;
  • allow pharmacy technicians to take primary responsibility for the preparation, assembly and dispensing of medicinal products in hospital aseptic facilities; and
  • enable pharmacists to authorise any member of the pharmacy team to hand out checked and bagged prescriptions in the absence of a pharmacist.

The first two proposals will not yet apply to Northern Ireland as Pharmacy Technicians are not currently a registered health profession here.  However, the Department of Health (NI) has established project structures to progress the regulation and registration of Pharmacy Technicians in Northern Ireland and make the necessary legislative changes to enable this.  Information on this project work can be found using the following link to the Pharmacy Technician Newsletter which will be updated by the Department on a quarterly basis.

The CPNI team is drafting a response to this consultation and is happy to take views from contractors (please send any comments to Ennis or myself at CPNI).  Contractors can also respond directly to the address given in the consultation documents.

The consultation closes on 29 February 2024.

Kind regards

Mike

SENT ON BEHALF OF
PROF MIKE MAWHINNEY
Head of Regulatory Affairs

Dear Colleague
The first update of concessionary prices were granted today for February 2024:
DrugPack SizeConcessionary Price
Atorvastatin 80mg tablets28£2.64
Azithromycin 250mg capsules6£4.67
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops3£4.55
Bumetanide 1mg tablets28£2.69
Clarithromycin 500mg tablets14£7.63
Co-amoxiclav 500mg/125mg tablets21£4.25
Co-codamol 30mg/500mg tablets30£1.32
Co-codamol 30mg/500mg tablets100£4.40
Cyclizine 50mg/1ml solution for injection ampoules5£5.56
Donepezil 5mg tablets28£1.85
Duloxetine 60mg gastro-resistant capsules28£3.65
Glycopyrronium bromide 200micrograms/1ml solution for injection ampoules10£11.80
Haloperidol 1.5mg tablets28£3.68
Hydrocortisone 2.5% cream15£46.83
Irbesartan 300mg tablets28£1.42
Isotretinoin 20mg capsules30£11.03
Ivabradine 7.5mg tablets56£4.51
Lamotrigine 100mg tablets56£3.51
Lamotrigine 200mg tablets56£5.15
Lamotrigine 25mg tablets56£1.92
Lamotrigine 5mg dispersible tablets sugar free28£10.05
Mebeverine 200mg modified-release capsules60£6.59
Memantine 10mg/ml oral solution sugar free50£45.46
Memantine 20mg tablets28£1.61
Metformin 1g modified-release tablets56£2.88
Metformin 500mg modified-release tablets56£1.83
Metformin 500mg/5ml oral solution sugar free150£26.50
Methylphenidate 10mg tablets30£3.09
Metoprolol 50mg tablets28£3.75
Montelukast 10mg tablets28£2.20
Montelukast 5mg chewable tablets sugar free28£1.21
Piroxicam 0.5% gel60£1.83
Piroxicam 0.5% gel112£3.43
Quinine sulfate 300mg tablets28£3.94
Risperidone 1mg/ml oral solution sugar free100£3.13
Simvastatin 80mg tablets28£1.61
Spironolactone 50mg tablets28£4.03

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
CPVS Update 13 issued on 12th February relating to the vaccination service.

SUMMARY

  • SPPG have issued important information regarding community pharmacies providing Influenza and COVID-19 vaccination services.
  • From 12th February 2024, any community pharmacy vaccinator can contact their local HSC Trust Occupational Health Team for Hep B vaccination.
  • This service will provide pre-exposure schedule, titres, and 5 year booster as per JCVI guidance.

ACTION

  • Contractors should review the CPVS update and share the information with all staff acting in the role of  Influenza and/or COVID-19 vaccinators.
  • Those requiring Hep B vaccination should contact the relevant Trust as detailed within the update to book an appointment.

If you have any queries about the Community Pharmacy Vaccination Service (CPVS) please contact Greg Miller (greg.miller@hscni.net) or Grainne McMahon (Grainne.McMahon4@hscni.net).

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive